Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks-Brief Report

Hongwei Ji1,2, Charumathi Sabanayagam3,4, Kunihiro Matsushita5

  • 1Tsinghua Medicine, Tsinghua University, Beijing, China (H.J., T.Y.W.).

Insights

Cardiovascular-kidney-metabolic (CKM) syndrome prevalence increased in both sexes, but women face higher mortality risks despite lower prevalence. Further research is needed to address sex disparities in CKM disease.

Area of Science:

  • Cardiology
  • Nephrology
  • Metabolic Health
  • Public Health
  • Epidemiology

Background:

  • Recent American Heart Association guidelines define clinical identification of cardiovascular-kidney-metabolic (CKM) syndrome.
  • Significant gaps exist in understanding sex-based differences in CKM syndrome prevalence and prognosis.
  • This study investigates the impact of sex on CKM syndrome trends and long-term mortality in the US.

Purpose of the Study:

  • To analyze sex-specific prevalence trends of CKM syndrome over three decades (1988-2018).
  • To evaluate the association between CKM syndrome severity and all-cause mortality, stratified by sex.
  • To identify potential sex disparities in CKM syndrome outcomes.

Main Methods:

  • Utilized data from 33,868 US adults (≥20 years) from the National Health and Nutrition Examination Survey (1988-2018).
  • Monitored all-cause mortality through December 31, 2019.
  • Employed multivariable Cox regression to assess sex-specific associations between CKM syndrome and mortality.

Main Results:

  • Overall CKM syndrome prevalence increased in both men and women from 1988 to 2018.
  • Men showed a larger increase in prevalent stage 3 CKM compared to women.
  • Worsening CKM severity was linked to increased all-cause and cardiovascular mortality in both sexes, with a significantly higher risk magnitude observed in women.

Conclusions:

  • Women with CKM syndrome experience a disproportionately higher mortality risk compared to men, despite lower prevalence.
  • Findings highlight the need to explore underlying pathophysiological mechanisms driving sex disparities in CKM disease.
  • Addressing these sex differences is crucial to mitigate multiorgan disease risks and close the health equity gap.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
25
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
278
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
102
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
57
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
734